I always used their $82 million Astellas deal as a gauge.
That's coming up on a decade and things change but it was a benchmark.
Since then they've "worked" with Sanofi, eTheRNA, IO Biotech, etc. and a cast of others that followers have never heard the results from their efforts.
The patent with Catalent from MACAVIVA is solid but sits dormant.
Stallergenes approved the Anergis work but still chose to go with alum.
Asthma reduction is a big claim to be made public. No interest from big pharma?
Dr. Peter Hotez had a televised platform and captive audience for two years and never mentioned his MYMX work once.
Were they actually even "working" with these companies?
Audited on taxes and got dropped by BDO. Mom and Pop accounting firm in Spokane, WA took over.
Longtime counsel Ernie Stern jumped ship.
The company that has them up "for sale" doesn't even list them on their web page.
Dr. Thomas Staehelin's run off to the wild, wild west (Serbia).
Mr. Kempers is at the pawn shop with office furniture.
Nobody has this bad of luck.
Stock Holders of Record: Anyone agree with this interpretation
Insider Holder Name Report
Date Time Shares Owned
Shares Owned Filing
Round Enterprises Ltd. 10% Owner 2015-09-04 07:12:30 141,006,552 Form 3
LUEBKE ERNST Chief Financial Officer 2007-06-22 11:05:38 10,079,418 Form 4
KEMPERS Ronald Hugo Gerard President and CEO and CFO 2023-01-31 15:08:47 17,000,000 Form 4
Staehelin Thomas Director 2010-12-20 15:59:38 0 12,812,907 12,812,907 Form 3
KHD HUMBOLDT WEDAG INTERNATIONAL LTD. 10% Owner 2006-01-17 13:50:49 1,705,250
6,715,790 8,421,040 Form 4
ROCHET CHRISTIAN Director 2009-07-28 11:44:33 5,459,862 Form 4
Stegmann Antonius Johannes CSO 2014-01-29 15:31:55 4,150,000 Form 3
Martin Jacques Francois CEO 2010-12-02 12:29:24 1,930,307 2,080,307 Form 4
Stern Ernest M Director 2008-06-23 17:30:08 1,500,000 Form 4
Fleury Sylvain CSO 2014-03-19 21:41:09 1,150,000 Form 4
Ruegg Marcel B. Director 2023-01-31 15:08:52
PCI Biotech, preclinical research collaborator, performs write down of share capital.
September 1, 2023.
New address of shared office space has yet to be updated on Mymetics or Biopole website.
"Net cash provided in investing activities was €92 during the six-months ended June 30, 2023, due to sales of office equipment in Leiden, and €2 used during the same period in 2022, related to new IT equipment in Epalinges." - August 10-Q
Good job on selling used office equipment in Leiden.
Why was new IT equipment in Epalinges needed if all you do is submit three 10-Q's and an annual report?
How about an update on the ongoing final studies of HIV vaccine candidate?
Is Uncle Ulrich relocating back to South America after maximizing shareholder value for common holders?
And where is MFO heading in the next five years?
I’ll leave that question to the younger partners!
In order for insiders to be selling now there would have to be a filing, especially with the company up for sale. They own more than 50% of the outstanding shares so you wouldn't be able to buy enough for a takeover. They wouldn't let that happen. The las two springs the stock has made a pop. If they didn't announce a bid process in February, you probably could have gotten 6-8 cents this spring sometime even without them putting out PR's. Two and a half years ago it was trading at a price 100 times more than it is now. Now that's creating shareholder value.
If anything, I think Kempers friends and family are probably buying shares now. As siar said Kempers did buy more shares before they put the company up for sale. In one of the recent filings, he said they were in discussion with an international biotech company. That was worded differently than before.
The question is if they make a deal will the shareholders outside the inner circle benefit. I'm not sure how they could structure a deal without including us. My patience is running thin with management. Maybe we should take control of the situation. Give them an option of letting us know what's really going, sell the company by a certain date or we start a shareholder lawsuit and tie them up in court for years. They have more to lose than we do. Just a thought.
"90mill debt wouldn't or couldn't that be written off in some way."
It could, of course. But as long as the company has assets, these debt holders have priority.
And (I think all) of that debt is convertible. They will try to get back as much as possible. Shareholders will get the - possibly non-existent - rest.
"It's evident that its unlikely that it will ever be paid."
Is it? I don't think so. And it seems certain to me, that Mr. Kempers thinks he can get much more than 100 million for the company. Remember, he recently did put his money in the company. If he thinks that debt will never be payable, he would have destroyed his money.
I am sure he has at least one seriously interested company, but that company or companies are not willing to pay enough. Who could resent them trying to make a bargain. The problem seems to me, that there are no competing interested parties and therefore are not going to outbid each other.
Thanks that certainly makes things much clearer. 90mill debt wouldn't or couldn't that be written off in some way. It's evident that its unlikely that it will ever be paid.
Most of the shares are not in public float, probably not all shareholders would sell at that price, and one would buy a company with, what, 90 million debt that could be converted into shares.
But you can send a buyout offer to Mr. Kempers. I am wondering if he would reply.
In my opinion he is trying to win a huge gamble. If we would and could fall to less than 0.0005 I would buy a few million shares as a lotto ticket.
Help Here. 303M shares outstanding. Purchase all for .002 per share that's $ 606,000.00 Isn't that kind of a steal! Anyone know what the cost to buy a company to have complete control of an OTC traded company is? I'm researching it now but I remember its been some years when I wanted my company to go public. I thought it was around 200k to buy and get a clear company to start out with. For 600k could one have rights to the patents and tradeable company? Any Thoughts
According to insider peek there are no insider shareholders, I hope i am wrong
Trying to Calculate Large Volume of Shares. Insider selling??. Market Makers getting preferential buying at low prices to facilitate a push higher??. or is this just stick a fork in it its over. SAGA continues. Just like reality TV. Just need more feedback to keep it interesting. A few hints or somethings from MYMX would always be fun..
And it continues today... April was bad but the volume in that span was comparatively low - less than 3 million shares over two days. Even with the 300% drop it was kind of hard to stick a fork in it at that time. Now it's just hard to believe that with all they claim to have in tech and patents that the stock traded down to triple zeros. What have they been doing all these years?
I didn't have high hopes after April but I thought there would at least be an offer close to the average of the insiders. The recent action seems to indicate that the market expects the insiders to feather their nest and zero out everyone else. Maybe the company is sitting on some positive info but the market action isn't confirming that,
Good luck to all
Moving Help Needed : August 31st. 9:00AM
Excellent opportunity for Biopole Startup's to get hands on experience of reducing burn rate.
Volunteers requested with a strong back and positive attitude.
Call +41 216534535 if you can assist.
Route de la Corniche 4
"the office lease agreement for Epalinges has been terminated as of August 31, 2023, and the Company is leasing a shared office space on a three month’s lease basis." - August 2023. 10-Q.
Delisting at under .001. But we’ve also been under .01 for a long time too. Who knows what’s going on or what will happen.
Based on the Latest Trading Looks Like .0001 is coming. The Boat is sinking. I think someone stated if it hits .0001 automatic delisting. Is that what I remember. Do I have that right. Found It from Templar I believe " In addition, the Company has been informed that in the event that the Company’s closing bid price falls below $0.001 at any time for five consecutive "
In the last 2 days I believe someone or group has acquired approx 5 million shares @ an average price of .002. Now this is just speculation. I think IMHO that this market drop was intentional. In the next 5 to 10 days will watch and see how many more shares are traded and the action. So many times I have seen a stock drop just like this only to be catapulted forward to new heights. To much silence from Kemper and kronies makes me think that something is on the table. Maybe its just hopefull thinking that Kemper is a good person looking out for himself and his shareholders but I here to wait and see. Next week should be interesting either way..
If were admitting selling. I sold off some shares to start the selling yesterday. Bought back the shares at a lower price. I'm going to be here till the end
What other company puts itself up for sale and loses 95% of its value. This company should have gone private years ago. They've had total disregard for shareholders outside the inner circle. They stopped putting out PR's a few years ago. The only way we get any info is through quarterly reports. 6 months after they put the company up for sale, they claw back a patent and then say it will take several months to do so. That was for a partial payment on 6 million owed so how much could that be worth? If that holds up any sale of this company that's horrible planning. Kempers should not be getting a paycheck now. They said they don't care if the stock gets delisted. Maybe it doesn't matter to them, but it makes a big difference to those outside the company holding the shares. Some brokers won't allow you to trade the stock once it gets delisted. It will just sit there in your account until they either make a sale or you take a tax loss. I don't blame anyone for selling. I'm choosing to hold at this point. The only good thing in the last 2 filings were they're taking the effort to claw back the patent and Round and Eardley are still loaning the company money. Unfortunately, this company has lost shareholder trust. I'm pissed off at management. How can you not be. At this point they could pull something dirty and screw long term shareholders. Don't know. They know darn well what's going on and refuse to let us in on it. It's unfortunate because some long-term shareholders are selling at a loss now. Six months ago, Kempers said a lawsuit would slow down the process of selling the company. They need to get their arse in gear or that may not be avoidable.
Nobody with any experience in the market would be mad at YOU. The demise of MYMX is not your fault.
Maybe Kempers and his cronies are planning to take this thing private and completely screw over retail investors. I certainly feel like they screwed me over but that's the game we're playing -- we have to make guesses and gamble and sit in the shadows and hope to find money that falls out of the pockets of the insiders who know what's going on.
I gambled and lost here. Oh well. Best of luck to all who ride it out.
Thanks SP. It’s bonkers they can’t give us more information we know they have.
I think that was a real selloff today.
I took my loss in April and it hurt. see post 27397
I wonder if it will be possible to follow where the patent ends up.
I want u all to know it was me selling today. I am agitated by a couple of things. I didn't want to sell. I still don't. I still carry a good amount of shares. This isn't my intention to make you all mad. I think Mr Kempers has been less than forthright. I apologize to all of you but once I saw the ask at .086 I was irritated. I am done selling at the moment but I'm hoping that the powers that b give us some sort of update other than these stupid q's....they owe all of us some sort of explanation. Most of all Phosphene...You my friend will always be someone I admire. I am irritated in general with the whole market. Love you all and wish us nothing but great things in our lives. I'll keep pushing even though the stack is stacked against us.
Here is a thought. It's officially over.
I hope you are correct or else I have a lot of tax write offs for losses lol
Here is a thought. 6.5 million shares intentionally sold to market makers so when news does come out on a sale the market makers are making money to push the stock high and higher. I am going to go with that and see how the next 20 days roll out. I would think that if something is going to happen its going to happen soon. The market makers are going to want to capitalize on the large volume of trade today. Looking for another drop tomorrow to .001 then push possible Monday or Tuesday. I have seen it before push it low then Boom.. Good Luck to the ones who held me included..
Is leadership trying to intentionally take this company private?
They don't want bankruptcy because it would expose and identify the names on the insider trust.
Dr. Thomas Staehelin could write a check and make it all go away.
Long time holder.
My faith is being challenged today.
I'm not selling at these levels.
Hope tomorrow is a better day for all.
MYMX ask .0022 6.47million Shares traded
Still hanging on here and trying to remain hopeful for a decent outcome however I am concerned there doesn't seem to be much of an underlying speculative interest in MYMX. I would be surprised if the purposed buyout details were a tightly guarded secret. Maybe they are but it seems someone always knows what's likely to happen and they act accordingly nudging the price up or down.
That said, even though there hasn't been a steady stream of accumulation, there hasn't been a real sell off either. Since any selling at all will produce disastrous results like today's beat down it's hard to judge. Maybe it's just retail guy throwing in the towel or a margin call. Volume is climbing now so maybe there will be a confirmation of sorts.
We'll see if anyone rushes in to buy down here,Cheers.
Thank you Staypositive1.
Did you see MYMX's consortium partner received The King's Award at Buckingham Palace?
What happened to that small percentage of a percentage arrangement with Upperton Pharma?
According to what I'm reading at the end of the paragraph they only have 5 days to file.
The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-CEN or Form N-CSR, or
portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or
transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day
following the prescribed due date;
The NT has been filed.
Surprising to me, Mr. Kempers writes: "[...] the Registrant will file its Form 10-Q no later than the fifteenth calendar day following the prescribed due date." Was there a recent change in obligations in the US, since if I remember correctly only 10-K's NT forms lead to a grace period of 15 days and 10-Q's only to 5 days?
I think the deadline was yesterday. If the 10-Q does not come before market open and no NT is published they should be in delay.
I would think they would want to take advantage soon. The market has a lot of penny annie stocks which are popping after the sp500 stocks are starting to peter out. A little like the 1999 penny stock runs but not as many as then when the internet stocks were the big thing. Just my opinion but I think the market about to make a reversal sometime in the next 6 to 9 months big time reversal.... Pennies stocks will push as the big boys look for fresh meat... MYMX should want to make a move soon if it really has some kind of pending offer..
Mymetics Corporation is US registered biotechnology company with its main offices in Switzerland and the Netherlands.
Focused on developing next generation preventative vaccines for infectious diseases.
Mymetics core technology and expertise are in the use of virosomes,
lipid-based carriers containing functional fusion viral proteins in combination with rationally designed antigens and membrane proteins.
Objective: "Build small / medium size innovative R&D virosome vaccine company with strong
partnerships, Phase II – III clinical vaccine pipeline and have optionality for M&A or sale."
Current Share Structure:
Outstanding Shares: 303.7 million (as of 01/18/2019 unchanged since 2014)
Floating Shares: 79.8 million* (a/o 01/18/19)
Rationale and Impact of MACIVIVA
With few exceptions, commercialized vaccines are generally delivered by injection through the intramuscular or subcutaneous route.
Vaccines contain immunogens classically found within a large variety of biological compounds such as peptides, proteins, glycoproteins and sometimes carbohydrates and lipids.
These immunogens may trigger the immune system for producing antibodies and/or cytotoxic T cells for preventing the pathogen transmission or blocking and/or slowing down the disease progression.
However, these vaccines generally exist as liquid formulation that are inherently prone to physical and/or chemical modifications. The cold chain storage is still fundamental for preserving the
bioactivity of most liquid and freeze-dried vaccines. For reconstituted freeze dried vaccines, they harbor important instability and must be used within hours and kept refrigerated. Vaccine degradation generally takes place
during shipment and/or storage of liquid or lyophilized products, which may affect the immunological properties of the immunogens, with unwanted immune responses or insufficient immune protection.
There is growing evidence that solid dosage formats (e.g. powder form) for vaccines may offer several advantages over the liquid formulations, such as the prevention of molecular motion and shear-induced degradation,
and slowing down modifications and degradation reactions involving water and oxygen radicals, resulting in improved stability, enhanced shelf-life of vaccines and greatly simplified logistics.
Expertise: R&D on virosome formulations
Project responsability: Investigating and compiling the results about the physical and biochemical properties of the virosome-based vaccines obtained by spray-drying and lyophilization.
Expertise : Non-GMP and GMP virosome production, clinical development
Project responsability: Excipient selection for liquid virosomes, supervising the non-GMP and GMP manufacturing of the liquid virosomes and development of analytical methods.
Expertise: Non-GMP and GMP Spray drying
Project responsability: Identification of excipients and experimental conditions suitable for virosome spray drying, production of non-GMP and GMP powder forms for nasal and oral delivery.
CATALENT U.K. SWINDON ZYDIS LIMITED
Expertise: Zydis technology for fast-dissolving tablet, world leader in drug formulation and distribution
Project responsability: Identification of excipients and experimental conditions suitable for virosome lyophylization, according to the Zydis technology, non-GMP and GMP tablets for sublingual delivery.
CHIMERA BIOTEC GMBH
Expertise: Ultra sensitive immunoassays development and bioanalysis based on Imperacer® (Immuno-PCR) technology.
Project responsability: Immunogenicity study in animals with spray-dried and lyophilized virosomes. Imperacer® immunoassay development and evaluation of the vaccine-induced antibody response.
Expertise: R&D, non-GMP and GMP manufacturing of API, world supplier
Project responsability: Process Development and manufacture of peptide P1, GMP-grade, including development and validation of analytical methods.
Vaccines are poorly accessible in developing countries
Vaccines require cold-chain storage and are often delivered by injection, which is undesirable, less safe and more expensive to administer.
Developing thermostable solid form vaccines through non-invasive routes may represent a long-term global solution to the vaccination challenge (Amorij, 2008).
Virosomes are an efficient vaccine delivery system
Virosomes are spherical, unilamellar lipid-based carriers, intercalated with functional glycoproteins to reflect the natural virus, however the lack of viral RNA means there is no risk of infection
(Figure 1). Virosomes can be tagged with different antigens and adjuvants, meaning they can be tailored to target different viruses, and offer increased immunogenicity over inactivated viruses.
Currently, virosomal influenza vaccines are only available in liquid form (Amorij, 2008).
Spray drying can produce dry powders for a range of dosage forms, including inhaled or nasal drug delivery.
A dry powder is formed when a liquid feed solution or suspension is atomised using a spray nozzle, and rapidly dried using hot air. However, while the drying process is gentle due to evaporative cooling,
there is still the potential to stress and inactivate vaccine components. It has been found that subunit and live-attenuated vaccines (and other delicate molecules such as proteins)
can be protected during processing b by incorporating them in an amorphous sugar matrix, which also offers longer term stability during storage (Kanojia, 2016).
A method has been developed to produce a powder form of virosome based influenza vaccine using spray-drying.
Formulations have been optimised for oral and nasal delivery.
Virosomal technology is approved by the FDA for use in humans, and has a high safety profile
Virosomes are biodegradable, biocompatible, and non-toxic12
No disease-transmission risk
No autoimmunogenity or anaphylaxis10
Broadly applicable with almost all important drugs (anticancer drugs, proteins, peptides, nucleic acids, antibiotics, fungicides)
Enables drug delivery into the cytoplasm of target cell
Promotes fusion activity in the endolysosomal pathway
Protects drugs against degradation